Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen
We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek's d...
Na minha lista:
| Publicado no: | J Virol |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC135982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11861834/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.6.2676-2682.2002 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
